期刊文献+

内镜下硬化剂治疗在食管胃静脉曲张破裂出血治疗中的临床疗效 被引量:7

Clinical Efficacy of Endoscopic Sclerosis in Treatment of Esophageal Varices Bleeding
下载PDF
导出
摘要 目的探讨内镜下应用硬化剂治疗食管胃底静脉曲张破裂出血的临床效果及安全性。方法回顾性总结167例肝硬化致食管胃底静脉曲张患者的临床资料,包括内镜下硬化剂治疗联合药物治疗108例,单纯药物治疗59例,统计两组治疗的有效率、死亡率、再出血率进行对比分析。结果硬化剂治疗组中91例出血终止,17例患者死亡。结论在控制食管胃静脉曲张破裂急性出血中,内镜下硬化剂治疗就较单纯内科保守治疗效果佳,存活率高。 Objective To explore the clinical efficacy and safety of endoscopic application of the treatment of esophageal gastric varices bleeding.Methods Retrospectively analyzed 167 cases of esophageal varices clinical data,included 108 cases treated with endoscopic therapy combined with drug therapy, 59 cases treated with drugs alone,and the two groups were treated with efficiency ,mortality,and then bleeding rate.Results In the treatment group, 91 patients died of bleeding and seventeen patients died.Conclusion In the control of esophageal gastric varices bleeding,endoscopic sclerosis agent for the treament of acute hemorrhage,better than the conservative treatment in the department of internal medicine,the survival rate is high.
作者 钱贤峰
出处 《中国继续医学教育》 2015年第29期119-121,共3页 China Continuing Medical Education
关键词 食管和胃静脉曲张 出血 内镜检查 硬化治疗 Esophageal and gastric varices Bleeding Endoscopy Sclerdtherapy
  • 相关文献

参考文献5

二级参考文献22

  • 1Gores GJ,Wiesner RH,Dickson ER,et al.Prospective evaluation of esophageal varices in primary biliary cirrhosis:development,natural history,and influence on survival[J].Gastroenterology,1999,96(6):1552-1559.
  • 2de Franchis R.Updating consensus in portal hypertension:report of the Baveno Ⅲ Consensus Workshop on definitions,methodology and therapeutic strategies in portal hypertension[J].J Hepatol,2000,33(5):846-852.
  • 3Patch D,Sabin CA,Goulis J,et al.A randomized,controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis[J].Gastroenterology,2002,123(4):1013-1019.
  • 4Poynard T,Cales P,Pasta L,et al.Beta-adrenergic-antagonists in the prevention of first gastrointestinal bleeding in patients with cirrhosis and oesophageal varices.An analysis of data and prognostic factors in 589 patients from four randomized clinical trials[J].N Engl J Med,2002,324(22):1532-1538.
  • 5Wiest R,Groszmann RJ.Nitric oxide and portal hypertension:its role in the regulation of intrahepatic and splanchnic vascular resistance[J].Semin Liver Dis,2001,19(4):411-426.
  • 6Groszmann RJ.Beta-adrenergic blockers and nitrovasodilators for the treatment of portal hypertension:the good,the bad,the ugly[J].Gastroenterology,1997,113(5):1794-1797.
  • 7Bosch J,Garcia-Pagan JC.Prevention of variceal rebleeding[J].Lancet,2003,361(9361):952-954.
  • 8Rossle M.Prevention of rebleeding from oesophageal-gastric varices[J].Eur J Gastroenterol Hepatol,2001,13(4):343-348.
  • 9Lo GH.Prevention of recurrent variceal bleeding[J].J Chin Med Assoc,2006,69(12):553-60.
  • 10Sarin SK,Govil A,Jain AK,et al.Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices:influence on gastropathy,gastric varices and variceal recurrence[J].J Hepatol,1997,26(4):826-832.

共引文献506

同被引文献69

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部